PRESTIGE BIOPHARMA
PRESTIGE BIOPHARMA IDC
PRESTIGE BIOLOGICS
Beyond technological discovery, expanding access to care for patients around the world
Innovative Drug
Development of First-in-Class therapeutics for unmet diseases
Biosimilar
Prominent Biosimilars pipelines for accelerating market access
Platform Technology
A drug delivery platform that enhances treatment convenience
Diagnostics
Diagnostics for Pancreatic cancer by detecting PAUF
Prestige Biopharma IDC Obtains ISO 9001 Certification for Global Quality Management System
Prestige Biopharma IDC Obtains ISO 9001 Certification for Global Quality Management System
Prestige Biopharma IDC announced that it has obtained ISO 9001 certification, the international standard for quality management systems.
ISO 9001 is an international standard established by the International Organization for Standardization (ISO) that evaluates whether an organization systematically manages and continuously improves quality standards across all aspects of its products and services. In the biopharmaceutical research and development field, ISO 9001 serves as an important benchmark for assessing the level of research process standardization, data reliability, and the stability of quality management systems.
Through this certification, Prestige Biopharma IDC has further strengthened its quality management framework across the entire research and development process and established an operational foundation aligned with global standards. Based on this system, the company aims to enhance research efficiency and data reliability while continuing to build a stable and sustainable R&D environment.
Sang-Seok Koh, CEO of Prestige Biopharma IDC, stated that the ISO 9001 certification formally recognizes that the company’s quality management system meets international standards. He added that the certification is expected to further enhance the quality credibility of all research pipelines currently under development, and that the company will continue to advance its quality management system across the entire R&D process.
Source: https://www.paxetv.com/news/articleView.html?idxno=260138
Read Prestige news >>